PL1961423T3 - Zastosowanie pneumocytów typu II w leczeniu chorób płuc związanych z zwłóknieniem płuc - Google Patents

Zastosowanie pneumocytów typu II w leczeniu chorób płuc związanych z zwłóknieniem płuc

Info

Publication number
PL1961423T3
PL1961423T3 PL06841789T PL06841789T PL1961423T3 PL 1961423 T3 PL1961423 T3 PL 1961423T3 PL 06841789 T PL06841789 T PL 06841789T PL 06841789 T PL06841789 T PL 06841789T PL 1961423 T3 PL1961423 T3 PL 1961423T3
Authority
PL
Poland
Prior art keywords
pulmonary
pneumocytes
treatment
type
diseases associated
Prior art date
Application number
PL06841789T
Other languages
English (en)
Inventor
Mollar Ana Maria Serrano
Autet Daniel Closa
Moreu José Oriol Bulbena
Original Assignee
Consejo Superior Investigacion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior Investigacion filed Critical Consejo Superior Investigacion
Publication of PL1961423T3 publication Critical patent/PL1961423T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL06841789T 2005-11-28 2006-11-27 Zastosowanie pneumocytów typu II w leczeniu chorób płuc związanych z zwłóknieniem płuc PL1961423T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200502939A ES2308877B1 (es) 2005-11-28 2005-11-28 Empleo de nuemocitos tipo ii en el tratamiento de enfermedades pulmonares que cursan con fibrosis pulmonar.
EP06841789A EP1961423B1 (en) 2005-11-28 2006-11-27 Use of type ii pneumocytes in the treatment of pulmonary diseases associated with pulmonary fibrosis
PCT/ES2006/070182 WO2007060278A1 (es) 2005-11-28 2006-11-27 Empleo de neumocitos tipo ii en el tratamiento de enfermedades pulmonares que cursan con fibrosis pulmonar

Publications (1)

Publication Number Publication Date
PL1961423T3 true PL1961423T3 (pl) 2012-09-28

Family

ID=38066937

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06841789T PL1961423T3 (pl) 2005-11-28 2006-11-27 Zastosowanie pneumocytów typu II w leczeniu chorób płuc związanych z zwłóknieniem płuc

Country Status (11)

Country Link
US (1) US9610305B2 (pl)
EP (1) EP1961423B1 (pl)
JP (1) JP5702521B2 (pl)
AT (1) ATE550027T1 (pl)
BR (1) BRPI0619353A2 (pl)
CA (1) CA2631172C (pl)
DK (1) DK1961423T3 (pl)
ES (2) ES2308877B1 (pl)
PL (1) PL1961423T3 (pl)
PT (1) PT1961423E (pl)
WO (1) WO2007060278A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2972226A1 (en) * 2014-12-24 2016-06-30 Ube Industries, Ltd. Cell culture supernatant fluid derived from lung tissue

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8609412B2 (en) * 1999-08-05 2013-12-17 Regents Of The University Of Minnesota Mapc generation of lung tissue
US20020164790A1 (en) 1999-12-07 2002-11-07 David Warburton Lung stem cells and lung regeneration
US7211247B2 (en) 2001-04-09 2007-05-01 University Of Southern California Lentivirus vectors for gene transfer to alveolar epithelial cells
GB0218332D0 (en) * 2002-08-07 2002-09-18 Imp College Innovations Ltd Preparation of type pneumocytes
CA2535683A1 (en) * 2003-08-11 2005-02-24 University Of South Florida Stem cell beacon
WO2005040391A1 (en) * 2003-10-27 2005-05-06 Murdoch Childrens Research Institute Compositions and methods for differentiating stem cells
EP1548100A1 (en) * 2003-11-11 2005-06-29 DeltaCell B.V. Inhibition of stem cell differentiation, enhancement of proliferation and selective induction of apoptosis by Wnt factors
ATE512212T1 (de) 2004-04-21 2011-06-15 Univ Minnesota Erzeugung von lungengewebe aus multipotenten adulten progenitorzellen (mapc)

Also Published As

Publication number Publication date
ES2308877B1 (es) 2009-10-26
DK1961423T3 (da) 2012-06-25
CA2631172C (en) 2014-08-05
JP2009517372A (ja) 2009-04-30
CA2631172A1 (en) 2007-05-31
ATE550027T1 (de) 2012-04-15
ES2384564T3 (es) 2012-07-09
PT1961423E (pt) 2012-06-28
EP1961423B1 (en) 2012-03-21
US20090220467A1 (en) 2009-09-03
ES2308877A1 (es) 2008-12-01
JP5702521B2 (ja) 2015-04-15
US9610305B2 (en) 2017-04-04
EP1961423A1 (en) 2008-08-27
WO2007060278A1 (es) 2007-05-31
BRPI0619353A2 (pt) 2011-09-27

Similar Documents

Publication Publication Date Title
HK1130261A1 (en) Bicyclic compounds and use as antidiabetics
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
UA92355C2 (en) urn:schemas-microsoft-com:office:smarttags2,4-DIAMINO-PYRIMIDINES USED AS AURORAINHIBITORS
WO2007058602A3 (en) Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia.
SG179120A1 (en) Novel compounds
WO2009068214A3 (de) Heteroaryl-substituierte piperidine
IL190913B (en) Preparations for the treatment of sweating disorders
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
EA201200253A1 (ru) Композиция для лечения муковисцидоза
PT1938839E (pt) Composições oftálmicas de estimulantes parassimpáticos e anti-inflamatórios para utilização no tratamento de presbiopia
PT2383271E (pt) Aminoquinolonas como inibidores de gsk-3
TW200722081A (en) New therapeutic combinations for the treatment or prevention of depression
ZA201201222B (en) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-derivatives,methods for the production thereof and use thereof for treating diseases
TW200700064A (en) Novel compounds
MX2010006204A (es) Derivados de oxindol 5,6-disubstituidos y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
MY150931A (en) Substituted oxazolidinones and their use
MX2009009362A (es) Forma de dosificacion novedosa.
TN2011000204A1 (en) Cycloundecadepsipeptide compounds and use of said compounds as a medicament
WO2007144057A3 (en) Antimicrobial carbon
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
MY162440A (en) 2,5-disubstituted arylsulfonamide ccr3 antagonists
EP1865954A4 (en) METHOD FOR AVOIDING OEDEM IN THE TREATMENT OR PREVENTION OF DISEASES AFFECTING PPAR GAMMA INCLUDING CANCER
TW200639155A (en) Thiazolidinones, their production and use as pharmaceutical agents
MX2008001428A (es) Compuestos de imidazolil-pirimidina para uso en el tratamiento de trastornos proliferativos.